805 results on '"Arnsten, Julia"'
Search Results
2. Overreporting of adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs in the HERO study
3. Available but inaccessible: patient experiences during the first 2 years of a primary care-based medical cannabis program at an academic medical center
4. Optimal hepatitis C treatment adherence patterns and sustained virologic response among people who inject drugs: The HERO study
5. Addiction Consult Service and Inpatient Outcomes Among Patients with Alcohol Use Disorder
6. Effect of self-efficacy among persons who inject drugs treated with direct-acting antivirals on Hepatitis C treatment initiation, duration, completion, adherence, and cure
7. Offering nurse care management for opioid use disorder in primary care: Impact on emergency and hospital utilization in a cluster-randomized implementation trial
8. Individual and Health System Factors for Uptake of Pre-exposure Prophylaxis Among Young Black and Latino Gay Men
9. Cannabis dispensary staff approaches to counseling on potential contraindications to cannabis use: insights from a national self-report survey
10. “It doesn’t make any sense to even try”: the disruptive impact of COVID-19’s first wave on people with chronic pain using medical cannabis in New York
11. Loss, liberation, and agency: Patient experiences of methadone treatment at opioid treatment programs during the COVID-19 pandemic
12. Self-reported and measured adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs: The HERO study
13. Injecting practices during and after hepatitis C treatment and associations with not achieving cure among persons who inject drugs
14. Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trial
15. Optimal hepatitis C treatment adherence patterns and sustained virologic response among people who inject drugs: The HERO study
16. Relationship between depressive symptoms and adherence to direct-acting antivirals: Implications for Hepatitis C treatment among people who inject drugs on medications for opioid use disorder
17. Pain catastrophizing and mental health phenotypes in adults with refractory chronic pain: A latent class analysis
18. Distrust in the Health Care System and Adherence to Direct-Acting Antiviral Therapy among People with Hepatitis C Virus Who Inject Drugs.
19. Evaluation of Algorithms Used for PrEP Surveillance Using a Reference Population From New York City, July 2016–June 2018
20. How medical are states’ medical cannabis policies?: Proposing a standardized scale
21. High HCV cure rates among people who inject drugs and have suboptimal adherence: A patient-centered approach to HCV models of care
22. Prevalence and Medication Treatment of Opioid Use Disorder Among Primary Care Patients with Hepatitis C and HIV
23. Abstinence-reinforcing contingency management improves HIV viral load suppression among HIV-infected people who use drugs: A randomized controlled trial
24. Factors Associated with Medical Cannabis Use After Certification: A Three-Month Longitudinal Study.
25. Documented opioid use disorder and its treatment in primary care patients across six U.S. health systems
26. Prevalence and treatment of opioid use disorders among primary care patients in six health systems
27. Loss, liberation, and agency: Patient experiences of methadone treatment at opioid treatment programs during the COVID-19 pandemic
28. Impact of an Opt-In eConsult Program on Primary Care Demand for Specialty Visits: Stepped-Wedge Cluster Randomized Implementation Study
29. PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment
30. Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs
31. Achieving Smoking Cessation Among Persons with Opioid Use Disorder
32. Super Learner Analysis of Electronic Adherence Data Improves Viral Prediction and May Provide Strategies for Selective HIV RNA Monitoring.
33. M132 - Depression Profiles and Hepatitis C Treatment Outcomes Among Persons who Inject Drugs: The Hero Study
34. S72 - The Association of Self-Report Adherence to Hepatitis C (HCV) Direct-Acting Antiviral (DAA) Therapy With Measured Adherence and Sustained Virologic Response Among People Who Inject Drugs (PWID) Receiving Opioid Agonist Therapy
35. Liberation Medicine: a Community Partnership and Health Advocacy Curriculum for Internal Medicine Residents
36. Dispensary Staff Perceptions About the Benefits, Risks, and Safety of Cannabis for Medical Purposes
37. Preliminary Evidence of the Association between Time on Buprenorphine and Cognitive Performance among Individuals with Opioid Use Disorder Maintained on Buprenorphine: A Pilot Study
38. Available but inaccessible: Patient experiences during the first two years of a primary care-based medical cannabis program at an academic medical center
39. Feasibility and acceptability of a peer influencer delivered social media based intervention to promote mental health awareness for young Black and Latinx gay and bisexual men and transgender women
40. ART adherence changes among patients in community substance use treatment: a preliminary analysis from MACH14
41. A Video-Observed Treatment Strategy to Improve Adherence to Treatment Among Persons Who Inject Drugs Infected With Hepatitis C Virus: Qualitative Study of Stakeholder Perceptions and Experiences
42. Toward better preparedness for the next pandemic
43. Reduction in Depressive Symptoms in People who Inject Drugs who Are Cured of Hepatitis C Virus Infection: The HERO Study.
44. The Use of Online Posts to Identify Barriers to and Facilitators of HIV Pre-exposure Prophylaxis (PrEP) Among Men Who Have Sex with Men: A Comparison to a Systematic Review of the Peer-Reviewed Literature
45. Neurocognitive, psychiatric, and substance use characteristics in opioid dependent adults
46. Additional file 2 of 'It doesn’t make any sense to even try': the disruptive impact of COVID-19’s first wave on people with chronic pain using medical cannabis in New York
47. Additional file 1 of 'It doesn’t make any sense to even try': the disruptive impact of COVID-19’s first wave on people with chronic pain using medical cannabis in New York
48. Nurse Care Management for Opioid Use Disorder Treatment: The PROUD Cluster Randomized Clinical Trial
49. Sex Differences in Comorbid Mental and Substance Use Disorders Among Primary Care Patients With Opioid Use Disorder
50. More intensive hepatitis C virus care models promote adherence among people who inject drugs with active drug use: The PREVAIL study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.